ANXA1 and Alzheimer disease: We measured ANXA1 level in the serum of the subjects (Controls, n = 20; patients with AD, n = 14) by enzyme‐linked immunosorbent assay (ELISA) and showed that it was significantly reduced in the serum of patients with AD (Fig. 2A, **P < 0.01).